The Business Roundtable said its members forecast that growth this year will clock in at 2.3%, down from last quarter's estimate of 2.6%.Politicsread more
Activists with Black Lives Matter, who met privately with Buttigieg in the weeks after police shot and killed Eric Logan, say the 37-year-old mayor brushed off their concerns...2020 Electionsread more
Wall Street economists think the Fed will cut rates by 25 basis points at its September meeting but have differing views about what will happen in the future.Marketsread more
Trump said he "is revoking" a federal waiver that allowed the state to craft its own rules on greenhouse gas emissions from vehicles.Politicsread more
The unspecified action comes after the U.S. accused Iran of carrying out the weekend attacks on critical Saudi oil installations.Politicsread more
As the Fed was meeting to consider cutting interest rates, it lost control of the very benchmark rate that it manages.Market Insiderread more
Drone and missile debris recovered by investigators at the Saudi Aramco attack site is proof of Iranian culpability, a Saudi defense ministry representative told media on...World Politicsread more
Four Wall Street firms downgraded FedEx after the company's poor earnings report.Marketsread more
Some worry the regulators will squander an opportunity to crack down on potentially monopolistic behavior due to their own infighting.Technologyread more
FedEx CEO Fred Smith is "basically implying that we're going to import" a global slowdown," says CNBC's Jim Cramer.Investingread more
Oil prices retreated after President Donald Trump said he ordered the Treasury Department to "substantially increase" sanctions on Iran.Energy Commoditiesread more
The decline in drug and biotech stocks took away Jim Cramer's breath on Tuesday. He pinned the decline to uncertainty surrounding the presidential election.
The staggering fall of Gilead to $73, down from a 52-week high of $111 left him speechless. The company has made fortunes on its Hepatitis C treatment, and yet the stock still trades at six-times earnings.
How is that possible?
"I almost hesitate to answer this question because it touches on the third rail that is politics … Hillary Clinton's bite could be every bit as bad as her bark when it comes to controlling drug pricing," the "Mad Money" host said.
It seemed possible to Cramer that the Republicans could lose not only the presidency, but the House and Senate, too. If that is the case, Cramer expects a Democratic wave to take over.
Right now the uncertainty and consequences of the election are so great, the market is screaming that it will not pay as much for drug stocks anymore.
"Given that the Republicans will still be able to filibuster in the Senate even if they lose their majority, this seems like an extreme reaction, but I can understand the sentiment," Cramer said.
The situation could go from a president that bullies as a form of teaching, to one that will bully the entire industry around, Cramer said. Regardless of what the political outcome is, the new narrative in the market is that investors are not comfortable buying drug stocks on the way down until after the election.
To make matters worse, it seemed to Cramer that money had no place to hide on Tuesday. In addition to drug stocks, the reverberations of a weak quarter from Alcoa were felt across the board — especially in aerospace companies.
Usually investors will turn to packaged goods as a default, but with a strong dollar and low yields they weren't a safe haven. The same went for banks, real estate investment trusts and utilities.
"I think a lot of what happens in this market is that because there is no new money coming in, it just sloshes all over the place. On a day like today, there is nothing to slosh into," Cramer said.
On a tough day, stocks in most sectors were tough to own. The only silver lining Cramer found was that when there is usually nowhere to run and hide in a big sell-off, bargains will surface on the second day, with technology giving investors the biggest bang for their buck.
"It's important not to be too big a slave to any one day, because otherwise with the selling off badly and at a three-week low, you'd think 'who needs this?' The answer is someone who wants to make money a little longer term, that's who," Cramer said.